Considering that CD44 and TNFRSF1A primarily function as receptors, while ANXA1 can participate in regulating the tumor immune microenvironment as a secreted protein [34], we focused on whether NRF2 regulates the tumor immune microenvironment through ANXA1. This evidence concerns the gene CD44 and neoplasm.